School of Medicine

Research

Molecular Histopathology & Analytical Microscopy (MHAM)

 

Director

Dr. Luis Del Valle
Louisiana Cancer Research Center, 1700 Tulane Ave., Suite 612, New Orleans, LA 70112
ldelva@lsuhsc.edu

 

Mission

The Cancer Center Molecular Histopathology & Analytical Microscopy Core (MHAM) provides LSU-LCMC Health Cancer Center investigators with expert histopathology, molecular pathology and microscopy to study cancer in cells and tissues. The Core offers experimental design and imaging studies that define tumor pathology and the expression, localization and interactions of cell-surface and intracellular molecules, including oncogenic viral proteins, using bright-field and confocal microscopy, immunohistochemistry, immunofluorescence, multiplexing, in situ hybridization and in situ proximity ligation (Duolink). Dr. Del Valle works directly with investigators to interpret findings and to prepare the data and figures needed for manuscripts and grant applications.

 

Core Description

MHAM is a state-of-the-art facility that provides advanced histopathology and microscopy services to investigators and clinicians conducting cancer research at the LSU-LCMC Health Cancer Center. The Molecular Histopathology section covers the full workflow from fixed tissue to stained slide: tissue processing, paraffin embedding, sectioning, construction of tissue microarrays, hematoxylin and eosin and special stains, immunohistochemistry, immunofluorescence, double labeling, TUNEL assays for apoptosis, in situ hybridization and Duolink proximity ligation. Dedicated microtomes keep human tumor specimens, viral PCR work and experimental animal tissue separate.

The Analytical Microscopy section offers bright-field, fluorescence, deconvolution, multispectral, confocal and whole-slide digital scanning microscopy. Together these methods determine protein expression patterns and localization, mRNA levels and subcellular distribution, and protein–protein and RNA–protein interactions within tumor cells and the surrounding microenvironment. Tissue microarrays allow many tumors to be assessed on a single slide, supporting efficient validation of cancer biomarkers across patient cohorts.

The Core’s work spans tumor biology, virus-associated cancers, cancer immunology and preclinical therapeutic studies, as reflected in its publication record on breast, colon, lung, brain, prostate, pancreatic and lymphoid malignancies. The Core helps investigators turn pathology findings into rigorous, publication-quality data for manuscripts and competitive cancer research grants.

 

Location

Louisiana Cancer Research Center (LCRC), 1700 Tulane Ave., 6th Floor, New Orleans, LA 70112

Molecular Histopathology

  • Leica TP1020 tissue processor (80 cassettes per load; multiple time programs)
  • TBS embedding station for manual preparation of paraffin blocks
  • Three Thermo HM340E microtomes: one for human samples, one dedicated to viral PCR procedures and one reserved for experimental animal tissue

Analytical Microscopy

  • Keyence BZ-X810 all-in-one fluorescence microscope
  • Nikon TE300 automated inverted microscope with deconvolution software (SlideBook 5.0)
  • Olympus BX51 with Mantra multispectral imaging digital camera (PerkinElmer)
  • Olympus FV1000 confocal microscope
  • Motic EasyScan Pro 6 digital slide scanning microscope

A) Molecular Histopathology

Service

COBRE Investigators

Program Members

Non-Member Investigators

Tissue Preparation

Tissue processing

$4.00 / cassette

$6.00 / cassette

$8.00 / cassette

Paraffin embedding

$3.00 / cassette

$4.00 / cassette

$6.00 / cassette

Sectioning

$4.00 / slide

$5.00 / slide

$7.00 / slide

Creation of tissue microarrays

$100 / slide

$140 / slide

$200 / slide

Histological Stains

Hematoxylin & eosin

$3.00 / slide

$4.00 / slide

$6.00 / slide

Special staining I (PAS)

$5.00 / slide

$7.00 / slide

$10.00 / slide

Special staining II (Trichrome)

$10.00 / slide

$14.00 / slide

$20.00 / slide

 Molecular Pathology

Immunohistochemistry

$15.00 / slide

$21.00 / slide

$30.00 / slide

Immunofluorescence

$12.00 / slide

$17.00 / slide

$24.00 / slide

Double labeling

$20.00 / slide

$25.00 / slide

$32.00 / slide

TUNEL assay

$20.00 / slide

$25.00 / slide

$30.00 / slide

In situ hybridization

$30.00 / slide

$40.00 / slide

$50.00 / slide

Duolink (proximity ligation)

$40.00 / slide

$50.00 / slide

$60.00 / slide

Analysis

Data analysis

$50.00 / slide

$80.00 / slide

$100.00 / slide

 

B) Analytical Microscopy

Service

COBRE Investigators

Program Members

Non-Member Investigators

Olympus BX51 (Comet assay)

$10.00 / hour

$14.00 / hour

$20.00 / hour

Keyence BZ-X800

$25.00 / hour

$35.00 / hour

$45.00 / hour

Nikon E400 (deconvolution)

$20.00 / hour

$28.00 / hour

$40.00 / hour

Motic EasyScan Pro 6 (digital scanning)

$35.00 / hour

$50.00 / hour

$70.00 / hour

Olympus FV1000 (confocal)

$50.00 / hour

$70.00 / hour

$90.00 / hour

 

Microscope reservations: please use iLab (https://my.ilabsolutions.com/service_center/3388/).

Tissue processing and histopathology services: please contact Dr. Del Valle directly.

  • Tissue processing, paraffin embedding and sectioning of human tumor and experimental animal tissue
  • Construction of tissue microarrays for cancer biomarker studies
  • Immunohistochemistry and immunofluorescence, including double labeling
  • In situ hybridization and in situ proximity ligation (Duolink)
  • Bright-field, fluorescence, confocal and whole-slide digital microscopy
  • Pathology consultation and figure preparation for manuscripts and grants

Advanced fluorescence microscope workstation in a laboratory setting. A research-grade microscope sits on a workbench beside a computer monitor displaying multicolored microscopy images of cells and cellular structures. A keyboard, mouse, and control devices are positioned in front of the monitor. The equipment is connected by cables and surrounded by laboratory instruments, illustrating biomedical or scientific imaging and analysis.

Fluorescence microscopy image showing multiple oval-shaped cell nuclei stained blue against a black background. Numerous bright red fluorescent spots are distributed throughout the nuclei, indicating labeled molecular targets or cellular structures. The image illustrates high-resolution cellular imaging used in biomedical research to visualize the localization and abundance of specific molecules within cells.

Fluorescence microscopy image of a layered tissue sample with blue-stained cell nuclei and green fluorescent labeling. Numerous oval blue nuclei are densely packed within the central tissue layer, while green fluorescent structures outline cells and form a network throughout the tissue. A distinct band of elongated green fibers appears along the lower portion of the image. The black background enhances contrast between the blue and green fluorescent signals. This image demonstrates cellular organization and protein localization within biological tissue and is representative of advanced biomedical research imaging.

Five side-by-side microscope images compare kidney tissue across a grading scale of injury. Labels indicate progression from no damage through minimal, moderate, and severe injury to advanced sclerosis. As severity increases, normal glomerular structures become increasingly replaced by blue-stained scar tissue, illustrating the progression of kidney disease.

Microscopic fluorescence image of a cell with a prominent blue nucleus on the left and clusters of red and green fluorescent signals throughout the cell body. Overlapping signals create yellow regions, highlighting areas where labeled cellular structures are located together. The black background provides strong contrast for the fluorescent markers.

Microscopic image of tissue containing scattered cells with blue-stained nuclei. Several cells are highlighted by brown staining that marks the presence of a specific protein or biological target. A zoomed inset in the lower-right corner shows greater detail of one intensely stained cell, illustrating positive marker expression within the tissue sample.

A collection of microscopic images and 3-D visualizations demonstrates the distribution of fluorescently labeled proteins within cells. Red, green, and blue markers highlight different cellular components, while merged images show where markers overlap. Several panels focus on ring-like intracellular structures, and accompanying 3-D reconstructions provide a detailed view of their shape and spatial arrangement at the microscopic scale.

Histological image of neural tissue containing numerous cells dispersed throughout a light pink tissue matrix. Several cells show dense purple staining, making them stand out from surrounding tissue. The image is representative of brain tissue analysis used in neuroscience and biomedical research to visualize cellular structures and marker expression.

  1. Dela Cruz FN, Giannitti F, Li L, Woods LW, Del Valle L, Delwart E, and Pesavento PA. (2013). Novel Polyomavirus associated with Brain Tumors in Free-Ranging Raccoons, Western United States. Emerging Infectious Diseases; 19 (1): 77-84 (PMID: 23260029)
  2. Errami Y, Brim H, Oumouna-Benachour K, Oumouna M, Naura AS, Kim H, Ju J, Davis CJ, Kim JG, Ashktorab H, Fallon K, Xu M, Zhang J, Del Valle L, and Boulares AH. (2013). ICAD deficiency in human Colon Cancer and predisposition to colon tumorigenesis: linkage to apoptosis resistance and genomic instability. PLoS One; 8 (2): e57871 (PMID: 23451280)
  3. Morrow K, Hernandez CP, Raber P, Del Valle L, Wilk AM, Majumdar S, Wyczechowska DD, Velasco C, Cole J, Reiss K, and Rodriguez PC. (2013). Anti-leukemic mechanisms of Pegylated Arginase in acute lymphoblastic T cell leukemia. Leukemia; 27 (3): 569-577 (PMID: 22926702)
  4. Guo G, Marrero L, Rodriguez P, Del Valle L, Ochoa A, and Cui Y. (2013). Trp53 inactivation in the tumor microenvironment promotes tumor progression by expanding the immunosuppressive lymphoid-like stromal network. Cancer Research; 73 (6): 1668-1675 (PMID: 23319800)
  5. Dai L, Bai L, Lu Y, Xu Z, Reiss K, Del Valle L, Kaleeba J, Toole BP, Parsons C, and Qin Z. (2013). Emmprin and KSHV: New partners in viral cancer pathogenesis. Cancer Letters; 337 (2): 161-166 (PMID: 23743354)
  6. Struckoff AP, Rana MK, Kher SS, Burow ME, Hagan JL, Del Valle L, and Worthylake RA. (2013). PDZ-RhoGEF (PRG) is essential for CXCR4-driven Breast tumor cell motility through spatial regulation of RhoA. Journal of Cell Science; 126 (19): 4514-4526 (PMID: 23868972)
  7. Qin Z, Dai L, Trillo-Tinoco J, Senkal C, Wang W, Reske T, Bonstaff K, Del Valle L, Flemington E, Voelkel-Johnson C, Smith CD, Ogretman B, and Parsons C. (2014). Targeting Sphingosine Kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma. Molecular Cancer Therapeutics; 13 (1): 154-164 (PMID: 24140934)
  8. Dai L, Trillo-Tinoco J, Bai L, Kang B, Xu Z, Wen X, Del Valle L, and Qin Z. (2014). Systematic analysis of a Xenograft mice model for KSHV(+) Primary Effusion Lymphoma (PEL). PLoS One; 9 (2): e90349 (PMID: 24587336)
  9. Giannitti F, Higgins RJ, Pesavento P, DelaCruz F, Clifford D, Piazza M, Parker Struckhoff A, Del Valle L, Bollen AW, Puschner B, Kerr E, Gelberg H, Mete A, McGraw S, and Woods LW. (2014). Temporal and geographical clustering of Polyomavirus-associated olfactory sarcomas in ten free-ranging raccoons (Procyon lotor). Veterinary Pathology; 51 (4): 832-845, July 2014 (PMID: 24045888)
  10. Sierra RA, Thevenot P, Raber PL, Cui Y, Parsons C, Ochoa AC, Trillo-Tinoco J, Del Valle L, and Rodriguez PC. (2014). Rescue of Notch-1 signaling in antigen specific CD8+ T cells overcomes tumor-associated T cell suppression an enhances immunotherapy in cancer. Cancer Immunology Research; 2 (8): 800-811, August 2014 (PMID: 24830414)
  11. Ripple M, Parker Struckhoff A, Trillo-Tinoco J, Li L, Margolin DA, McGoey R, and Del Valle L. (2014). Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-Catenin in Colon Cancer. PLoS One; 9 (9): e106257, September 17th 2014 (PMID: 25229241)
  12. Dai L, Trillo-Tinoco J, Bai A, Chen Y, Bielawski J, Del Valle L, Smith CD, Ochoa AC, Qin Z, and Parsons C. (2015). Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression. Oncotarget; 6 (27): 24,246-24,260, September 15th 2015 (PMID: 26327294)
  13. Hossain F, Al-Khami AA, Wyczechowska D, Hernandez C, Zheng L, Reiss K, Del Valle L, Trillo-Tinoco J, Rodriguez PC, and Ochoa AC. (2015). Inhibition of fatty acid oxidation modulates immunosuppressive functions of Myeloid-Derived Suppressor Cells and enhances cancer therapies. Cancer Immunology Research; 3 (11): 1236-1247, November 2015 (PMID: 26025381)
  14. Dai L, Trillo-Tinoco J, Cao Y, Bonstaff KP, Doyle L, Del Valle L, Whitby D, Parsons CH, Reiss K, Zabaleta J, and Qin Z. (2015). Targeting HGF/c-MET induces cell cycle arrest, DNA damage and apoptosis for primary effusion lymphoma. Blood; 126 (26): 2821-2831, December 24th 2015 (PMID: 26531163)
  15. Kadri F, Pacifici M, Wilk A, Parker Struckhoff A, Del Valle L, Hauser KF, Knapp PE, Parsons C, Jeansonne D, Lassak A, and Peruzzi F. (2015). HIV-Tat inhibits SC35-mediated Tau exon 10 inclusion through upregulation of DYRK1A Kinase. Journal of Biological Chemistry; 290 (52): 30,931-30,946, December 25th 2015 (PMID: 26534959)
  16. Dai L, Trillo-Tinoco J, Chen Y, Bonstaff K, Del Valle L, Parsons C, Ochoa AC, Zabaleta J, Toole BP, and Qin Z. (2016). CD147 and downstream ADAMTSs promote the tumorigenicity of Kaposi's sarcoma-associated herpesvirus infected endothelial cells. Oncotarget; 7 (4): 3806-3818, January 26th 2016 (PMID: 26675551)
  17. Garay J, Piazuelo MB, Majumdar S, Li L, Trillo-Tinoco J, Del Valle L, Schneider BG, Delgado AG, Wilson KT, Correa P, and Zabaleta J. (2016). The homing receptor CD44 is involved in the progression of precancerous gastric lesions in patients infected with Helicobacter pylori and in the development of mucous metaplasia in mice. Cancer Letters; 371 (1): 90-98, February 1st 2016 (PMID: 26639196)
  18. Dai L, Qiao J, Nguyen D, Struckhoff AP, Doyle L, Bonstaff K, Del Valle L, Parsons C, Toole BP, Renne R, and Qin Z. (2016). Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus. Oncotarget; 7 (9): 10,459-10,471, March 1st 2016 (PMID: 26859574)
  19. Maggi EC, Trillo-Tinoco J, Parker Struckhoff A, Vijayaraghavan J, Del Valle L, and Crabtree JS. (2016). Retinoblastoma-binding protein 2 (RBP2) is frequently expressed in neuroendocrine tumors and promotes the neoplastic phenotype. Oncogenesis; 5 (8): e257, August 22nd 2016 (PMID: 27548814)
  20. Bonsignore L, Passelli K, Pelzer C, Perroud M, Konrad A, Thurau M, Stürzl M, Dai L, Trillo-Tinoco J, Del Valle L, Qin Z, and Thome M. (2017). A role for MALT1 activity in Kaposi's sarcoma-associated herpesvirus latency and growth of primary effusion lymphoma. Leukemia; 31 (3): 614-624, March 2017 (PMID: 27538487); PMCID: PMC5339436
  21. Al-Khami AA, Ghonim MA, Del Valle L, Ibba SV, Zheng L, Pyakurel K, Okpechi SC, Garay J, Wyczechowska D, Sanchez-Pino MD, Rodriguez PC, Boulares AH, and Ochoa AC. (2017). Fueling the mechanisms of Asthma: increased fatty acid oxidation in inflammatory immune cells may represent a novel therapeutic target. Clinical & Experimental Allergy; 47 (9): 1170-1184, September 2017 (PMID: 28456994)
  22. Al-Khami AA, Zheng L, Del Valle L, Hossain F, Wyczechowska D, Zabaleta J, Sanchez MD, Dean MJ, Rodriguez PC, and Ochoa AC. (2017). Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells. OncoImmunology; 6, (10): e1344804, October 2017 (PMID: 29123954)
  23. Lassak A, Dean M, Wyczechowska D, Wilk A, Marrero L, Trillo-Tinoco J, Boulares AH, Sarkaria JN, Del Valle L, Peruzzi F, and Ochoa A, and Reiss K. (2018). Molecular and structural traits of Insulin Receptor Substrate 1/LC3 nuclear structures and their role in autophagy control and tumor cell survival. Molecular and Cellular Biology; 38 (10): e00608-17, April 30th 2018 (PMID: 29483302)
  24. Dai L, Qiao J, Del Valle L, and Qin Z. (2018). KSHV co-infection regulates HPV16+ cervical cancer cells pathogenesis in vitro and in vivo. American Journal of Cancer Research; 8 (4): 708-714, April 2018 PMID: (29736315)
  25. Dai L, Del Valle L, Miley W, Whitby D, Ochoa AC, Flemington EK, and Qin Z. (2018). Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's Sarcoma development. Oncogene; 37 (33): 4534-4545, August 16th 2018 (PMID: 29743595)
  26. Dai L, Chen J, Cao Y, Del Valle L, and Qin Z. (2018). Ribonucleotide Reductase inhibitor 3-AP induces oncogenic virus infected cell death and represses tumor growth. Journal of Cancer; 9 (23): 4503-4509, October 31st 2018 (PMID: 30519356)
  27. Dai L, Zhao M, Jiang W, Lin Z, Del Valle L, and Qin Z. (2018). KSHV co-infection, a new co-factor for HPV-related cervical carcinogenesis? American Journal of Cancer Research; 8 (11): 2176-2184, November 2018 (PMID: 30555737)
  28. Hossain F, Sorrentino C, Ucar DA, Peng Y, Matossian M, Wyczechowska D, Crabtree J, Zabaleta J, Morello S, Del Valle L, Burow M, Collins-Burow B, Pannuti A, Minter LM, Golde TE, Osborne BA and Miele L. (2018). Notch signaling regulates mitochondrial metabolism and NF-κB activity in triple-negative breast cancer cells via IKKα-dependent non-canonical pathways. Frontiers in Oncology; 8: 575, December 4th 2018 (PMID: 30564555)
  29. Sabol RA, Bowles AC, Côté A, Wise R, O'Donnell B, Matossian MD, Hossain FM, Burks HE, Del Valle L, Miele L, Collins-Burow BM, Burow ME, and Bunell BA. (2019). Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models. Breast Cancer Research; 21 (1); 67, May 22nd 2019 (PMID: 31118047)
  30. Stalinska J, Zimolag E, Panovich NA, Zapata A, Lassak A, Rak M, Dean M, Ucar-Bilyeu DA, Wyczechowska D, Culicchia F, Marrero L, Del Valle L, Sarkaria JN, Peruzzi F, Jusic BS, and Reiss K. (2019). Chemically modified variants of Fenofibrate with high anti-Glioblastoma efficacy. Translational Oncology; 12 (7): 895-907, July 2019 (PMID: 31078963)
  31. Del Valle L, and Piña-Oviedo S. (2019). Human Polyomavirus JCPyV and its role in Progressive Multifocal Leukoencephalopathy and Oncogenesis. Frontiers in Oncology; 9: 711, August 8th 2019 (PMID: 31440465)
  32. Chen J, Del Valle L, Lin HY, Plaisance-Bonstaff K, Forrest JC, Post SR, and Qin Z. (2019). Expression of PD-1 and PD-Ls in Kaposi's Sarcoma and regulation by oncogenic Herpesvirus lytic reactivation. Virology; 536: 16-19, October 2019 (PMID: 31394407)
  33. Ronis MJ, Mercer KE, Shankar K, Pulliam C, Pedersen K, Ingleman-Sundberg M, Friso S, Samuelson D, Del Valle L, Taylor C, and Welsh DA. (2020). Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and Cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein. Chemo-Biological Interactions; 325: 109131, July 1st, 2020 (PMID: 32417163)
  34. Hoang VT, Matossian MD, Ucar DA, Elliot S, La J, Wright MK, Burks HE, Perles A, Hossain F, King CT, Browning V, Bursavich J, Fang F, Del Valle L, Bhatt AB, Cavanaugh J, Flaherty PT, Anbalagan M, Rowan B, Bratton ME, Nephew KP, Miele L, Collins-Burow BM, Martin EC, and Burow ME. (2020). ERK5 is required for tumor growth and maintenance through regulation of the extracellular matrix in Triple Negative Breast Cancer. Frontiers in Oncology; 10: 1164, August 3rd 2020 (PMID: 32850332)
  35. Chang TC, Matossian MD, Elliot S, Burks HE, Sabol RA, Ucar D, Wathieu H, Zabaleta J, Del Valle L, Gill S, Martin E, Riker AI, Miele L, Bunnell BA, Burow ME, and Collins-Burow BM. (2020). Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor. PLoS One; 15 (10): e0226464, October 9th 2020 (PMID: 33035223)
  36. Barrett L, Dai L, Del Valle L, and Qin Z. (2020). Role of Interleukin-1 (IL-1) family members and signaling pathways in KSHV pathogenesis. Frontiers in Cellular and Infection Microbiology; 10: 587,929, October 30th, 2020 (PMID: 33194830)
  37. Del Valle L, Sweet T, Parker-Stuckhoff A, Perez-Liz G, and Piña-Oviedo S. (2020). JCPyV T-Antigen activation the anti-apoptotic Survivin promoter; it's role in the development of Progressive Multifocal Leukoencephalopathy. Viruses; 12 (11): E1253, November 3rd 2020 (PMID: 33153187)
  38. Chen J, Goyal N, Dai L, Lin Z, Del Valle L, Zabaleta J, Liu J, Post S, Foroozesh M, and Qin Z. (2020). Developing new Ceramide analogs and identifying novel sphingolipid-controlled genes against a virus-associated Lymphoma. Blood; 136 (19): 2175-2187, November 5th 2020 (PMID: 32518949)
  39. Del Valle L, and Khalili K. (2021). Induction of brain tumors by the Archetype strain of human neurotropic JCPyV in a transgenic mouse model. Viruses; 13 (2): 162, January 22nd 2021 (PMID: 33499370)
  40. Ghonim MA, Ibba SV, Tarhuni AF, Errami Y, Luu HH, Dean M, El-Bahrawy AH, Wyczechowska D, Benslimane IA, Del Valle L, Al-Khami A, Ochoa AC, and Boulares AH. (2021). Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer. Journal for ImmunoTherapy of Cancer; 9 (1): e001643, January 25th 2021 (PMID: 33495297)
  41. Del Valle L, Dai L, Cao Y, Lin HY, Lin Z, Chen J, Post SR, Xu Z, and Qin Z. (2021). Role of EIF4G1 network in Non-Small Cell Lung Cancers (NSCLC) cell survival and disease progression. Journal of Cellular and Molecular Medicine; 25 (6): 2795-2805, March 14th 2021 (PMID: 33539648)
  42. Dean M, Ochoa JB, Sanchez-Pino MD, Zabaleta J, Garai J, Del Valle L, Wyczechowska D, Buckner Baiamonte LB, Philbrook P, Majumder R, Vander Heide RS, Dunkenberger L, Thyllur RP, Nossaman B, Roberts WM, Chapple AG, Wu J, Hicks C, Collins J, Luke B, Johnson R, Koul HK, Rees CA, Morris CR, García-Diaz J, and Ochoa AC. (2021). Severe COVID-19 is characterized by an impaired Type I Interferon response and elevated levels of Arginase producing Granulocytic Myeloid Derived Suppressor Cells. Frontiers in Immunology; 12: 695972, July 14th 2021 (PMID: 34341659)
  43. Means-Powell JA, Mayer IA, Ismail-Khan R, Del Valle L, Tonetti D, Abramson VG, Sanders MS, Lush RM, Sorrentino C, Mujumder S, and Miele L. (2022). A Phase Ib Dose Escalation Trial of RO4929097 (a γ-Secretase Inhibitor) in Combination with Exemestane in Patients with ER+ Metastatic Breast Cancer (MBC). Clinical Breast Cancer; 22 (2): 103-114, February 2022 (PMID: 34903452)
  44. Mondragón-Soto MG, Del Valle L, Gonzalez-Soto JA, and De Leo-Vargas RA. (2022). Metastatic primary brain Rhabdomyosarcoma in a pediatric patient: illustrative case. Journal of Neurosurgery: Case Lessons; 4 (4): CASE22-189, July 25th 2022 (PMID: 36046269)
  45. Zhang G, Wang Z, Bavara J, Kuhns KJ, Guo J, Ledet EM, Qian C, Lin Y, Fang Z, Zabaleta J, Del Valle L, Hu JJ, Mandal D, and Liu W. (2022). A recurrent ADPRHL1 germline mutation activates PARP1 and confers prostate cancer risk in African American families. Molecular Cancer Research; 20 (12): 1776-1784, December 2022 (PMID: 35816343)
  46. Khreefa Z, Barbier MT, Koksal AR, Love G, and Del Valle L. (2023). Pathogenesis and mechanisms of SARS-CoV-2 infection in the intestine, liver, and pancreas. Cells; 12 (2): 262, January 9th 2023 (PMID: 36672197)
  47. Barbier MT, and Del Valle L. (2023). Co-Detection of EBV and Human Polyomavirus JCPyV in a case of HIV-related Multifocal Primary Central Nervous System Diffuse Large B-cell Lymphoma. Viruses; 15 (3): 755, March 15th 2023 (PMID: 36992464)
  48. Vigolo M, Urech C, Lamy S, Monticone G, Zabaleta J, Hossain F, Wyczechowska D, Del Valle L, O-Regan R, Miele L, Lejal R, and Majumder S. (2023). The efficacy of CB-103, a first-in-class transcriptional Notch inhibitor, in preclinical models of breast cancer. Cancers; 15 (15): 3957, August 3rd 2023 (PMID: 37568775)
  49. Hossain F, Ucar DA, Monticone G, Ran Y, Majumder S, Larter K, Luu H, Wyczechowska D, Heidari S, Xu K, Shanthalingam S, Matossian M, Xi Y, Burow M, Collins-Burow BM, Del Valle L, Hicks C, Zabaleta J, Golde TE, Osborne BA, and Miele L. (2023). Sulindac Sulfide as a non-immune suppressive gamma-secretase modulator to target Triple-Negative Breast Cancer. Frontiers in Immunology; 14: 1244159, October 13th 2023 (PMID: 37901240)
  50. Ghonim M, Ju J, Pyakurel K, Ibba SV, Abouzeid MM, Rady HF, Matsuyama S, Del Valle L, and Boulares HA. (2024). Unconventional activation of PRKDC by TNF-α: Deciphering its crucial role in Th1-mediated inflammation beyond DNA Repair as part of the DNA-PK complex.Journal of Inflammation; 21: 14, April 30th 2024 (PMID: 38689261)
  51. Liu Z, Julius P, Mudenda V, Kang G, Del Valle L, West JT, and Wood C. (2024). Limited HIV-related neuropathologies and lack of immune activation in sub-Saharan African individuals with late-stage Subtype C HIV-1 infection. Journal of NeuroVirology; 30 (3): 303-315, June 2024 (PMID: 38943022)
  52. Monticone G, Huang Z, Hewins P, Cook T, Mirzalieva O, King B, Larter K, Miller-Esminger T, Sanchez-Pino MD, Foster T, Nichols O, Ramsay A, Majumder S, Wyczechowska D, Tauzier D, Gravois E, Crabtree JS, Garai J, Li L, Zabaleta J, Barbier MT, Del Valle L, Jurado KA, and Miele L. (2024). Novel immunomodulatory properties of Adenosine analogs promote their antiviral activity against SARS-CoV-2. EMBO Reports; 25 (8): 3547-3573, August 2024 (PMID: 39009832)
  53. Puttalingaiah RT, Dean MJ, Zheng L Philbrook P, Wyczechowska D, Kayes T, Del Valle L, Danos D, and Sanchez-Pino MD. (2024). Excess potassium promotes autophagy to maintain the immunosuppressive capacity of Myeloid-Derived Suppressor Cells independent of Arginase 1. Cells; 13 (20): 1736, October 19th 2024 (PMID: 39451254)
  54. Howard CM, De Carlo F, Sitta J, Kirven I, Dobbins GC, Penfornis P, Barbier M, Del Valle L, Larsen CT, Schutt EG, Li R, and Claudio PP. (2024). Microbubble-protected oncolytic virotherapy targeted by sonoporation induces tumor necrosis and T-lymphocyte infiltration in humanized mice bearing triple-negative breast cancer. International Journal of Molecular Sciences; 25 (24): 13,697, December 21st 2024 (PMID: 39769460)
  55. Prouse T, Larter K, Ghosh S, Kumar N, Mohammad M, Del Valle L, Majumder R, and Majumder S. (2025). Exogenous Protein S inhibits pancreatic ductal adenocarcinoma. Thrombosis Research; 245: 109233, January 2025 (PMID: 39626470)
  56. Hunter JJ, Del Valle L, Peruzzi F, and Reiss K. (2025). Cardiolipin dysregulation in Glioblastoma; effects on mitochondrial function, tumor cell death and sensitivity to mitochondria-targeting drugs. Journal of Cellular Physiology; 240 (5): e70045, May 15th 2025 (PMID: 40372980)
  57. Liu Z, Julius P, Yalcin D, Kang G, Himwaze CM, Mucheleng'anga LA, Del Valle L, West JT, and Wood C. (2025). Cellular tropism and viral genetics in appendix tissue reservoirs of subtype C HIV-1 infected aviremic persons. The Journal of Infectious Diseases; 232 (1): 90-100, July 15th 2025 (PMID: 40279384)
  58. Ingraham C, Polania Villanueva D, Macaluso A, Tramulta A, Vittori C, Hunter JJ, Rak M, Claudio PP, Ibrahim MA, Del Valle L, Peruzzi F, Jursic B, and Reiss K. (2025). Bypassing blood-brain barrier and glucose dependency of anti-glioblastoma drug candidates targeting mitochondrial respiration. Journal of Cellular Physiology; 240 (7): e70062, July 15th 2025 (PMID: 40665659)
  59. Bam A, Hu Y, Wu XC, Luo M, Rizvi N, Del Valle L, Zea AH, Hossain F, Danos DM, Zabaleta J, Ochoa A, Miele L, Trapido E, and Yu Q. (2025). Differential miRNA expressions linking environmental risk factors to Triple Negative Breast Cancer stages at diagnosis. Cancers; 17 (16): 2618, August 11th 2025 (PMID: 40867247)
  60. Hossain F, Gonzalez-Ramirez MI, Garai J, Polania-Villanueva DC, Li L, Nafees F, Manirujjaman M, Liu B, Majumder S, Wu XC, Hicks C, Del Valle L, Danos D, Ochoa A, Miele L, and Zabaleta J. (2025). Integrated miRNA-mRNA analyses of Triple-Negative Breast Cancer in black and white patients with or without obesity. International Journal of Molecular Sciences; 26 (18): 9101, September 18th 2025 (PMID: 41009685)
  61. Hossain F, Danos D, Zabaleta J, Wu XC, Del Valle L, Hicks C, Wu J, Tomsic J, Neuhausen S, Ding YC, Mukund K, Mesrizadeh Z, Subramaniam S, Ochoa A, Seewaldt V, and Miele L. (2025). Immunogenomic diversity of Triple-Negative Breast Cancers in obese and non-obese black and white women. NPJ Breast Cancer; 11 (1): 126, November 12th 2025 (PMID: 41224793)
  62. Mohammad MA, Kumar N, Ghosh S, Paysse A, Leonardi C, Pilli VS, Duhaylungsod ML, Lazartigues E, Polania-Villanueva D, Nouman S, Barrios LA, Chattopadhyay R, Yasmin R, Guilbeau A, Kumar M, Nguyen T, Zabaleta J, Li L, Del Valle L, Barbier MT, Majumder S, Mosnier LO, and Majumder R. (2025). Estrogen and obesity synergistically suppress Protein S via HIF1a, enhancing thrombotic potential. Journal of Clinical Investigation; 135 (22); e193976, November 17th 2025 (PMID: 41243971)